Silence Therapeutics (SLN) Statistics & Valuation Metrics - Stocknear

Silence Therapeutics

NASDAQ: SLN · Real-Time Price · USD
5.69
0.46 (8.80%)
At close: Sep 05, 2025, 3:59 PM
5.69
0.00%
After-hours: Sep 05, 2025, 04:10 PM EDT

Silence Therapeutics Statistics

Share Statistics

Silence Therapeutics has 47.23M shares outstanding. The number of shares has increased by 202.77% in one year.

47.23M
202.77%
0.01%
15.13%
37.67M
2,868
3.41%

Short Selling Information

The latest short interest is 770.45K, so 1.63% of the outstanding shares have been sold short.

770.45K
1.63%
2.06%
9.72

Valuation Ratios

The PE ratio is -7.17 and the forward PE ratio is -9.87. Silence Therapeutics's PEG ratio is 0.47.

-7.17
-9.87
7.51
14.6
2.42
-4.79
0.47
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Silence Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 11.14, with a Debt / Equity ratio of 0.

11.14
11.14
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$372.91K
$-390.59K
116
0.21
n/a

Taxes

845K
-1.9%

Stock Price Statistics

The stock price has increased by -69.49% in the last 52 weeks. The beta is 1.38, so Silence Therapeutics's price volatility has been higher than the market average.

1.38
-69.49%
5.73
5.31
55.97
84,124

Income Statement

In the last 12 months, Silence Therapeutics had revenue of 43.26M and earned -45.31M in profits. Earnings per share was -0.99.

43.26M
31.45M
-63.32M
-45.31M
-48.99M
-49.58M
-0.99
Full Income Statement

Balance Sheet

The company has 121.33M in cash and 117K in debt, giving a net cash position of 121.21M.

121.33M
117K
121.21M
-474.04M
165.23M
133.78M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -67.64M and capital expenditures -211K, giving a free cash flow of -67.85M.

-67.64M
-211K
-67.85M
-1.44
Full Cash Flow Statement

Margins

Gross margin is 72.7%, with operating and profit margins of -146.38% and -104.74%.

72.7%
-146.38%
-102.79%
-104.74%
-113.25%
-146.38%
-156.85%

Dividends & Yields

SLN does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for SLN is $25, which is 339.4% higher than the current price. The consensus rating is "Buy".

$25
339.4%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-2.3
3